Skip to main content
XIAMEN YAN PALACE BIOENGINEERING CO., LTD. logo

XIAMEN YAN PALACE BIOENGINEERING CO., LTD. — Investor Relations & Filings

Ticker · 1497 ISIN · CNE1000069X7 HKEX Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2025-09-05 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1497

About XIAMEN YAN PALACE BIOENGINEERING CO., LTD.

http://www.yanzhiwu.com

Xiamen Yan Palace Bioengineering Co., Ltd. is a prominent enterprise dedicated to the research, development, production, and marketing of high-quality modern Edible Bird's Nest (EBN) products. The company consistently focuses on technological innovation, maintaining a comprehensive R&D system that has earned provincial recognition as an Enterprise Technology Center. Yan Palace is recognized as the largest EBN product company in China's traceable bird's nest market, commanding a significant market share. Its operational assets include one of the world's largest bird's nest processing factories, supporting its mission to deliver premium, traceable EBN products to consumers.

Recent filings

Filing Released Lang Actions
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings Classification · 95% confidence The document is a short notice from the Hong Kong Stock Exchange regarding a trading halt for Carry Wealth Holdings Limited. It does not contain financial statements, management reports, or specific corporate actions like dividends or M&A. As it is a regulatory notice regarding trading status that does not fit into specific categories like 'DLST' (delisting) or 'SHA' (share issue), it falls under the general regulatory filing category.
2025-09-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings Classification · 85% confidence The document is the HKEX FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” for movements in share capital and issued/treasury shares, submitted to The Stock Exchange of Hong Kong under Main Board Rule 13.25C/GEM Rule 17.27C. It is a routine, mandated regulatory filing rather than an earnings release, annual report, call transcript, or any other specific category. It does not announce a specific corporate action such as a dividend, M&A, major shareholding change, or insider transaction, nor is it a notice that a full report is attached. Therefore it falls under the “Regulatory Filings” fallback category (RNS).
2025-09-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Regulatory Filings Classification · 90% confidence The document is a standardized monthly return (Form FF301) filed by a Hong Kong listed issuer to the HKEX detailing movements in share capital, issued shares, treasury shares, etc. It is not an earnings release, annual report, or a specific corporate action announcement (e.g., dividend, merger, management change) but rather a routine regulatory submission required under the Listing Rules. It does not announce a report publication nor describe a particular capital raising event. Therefore it falls under the general “Regulatory Filings” category (RNS).
2025-09-01 English
2025 INTERIM REPORT
Interim / Quarterly Report Classification · 99% confidence The document is titled '2025 Interim Report' and contains detailed financial statements such as consolidated statements of financial position, profit or loss, cash flow, and notes to the unaudited interim financial report. It includes management discussion and analysis, corporate governance information, auditor's review report, and comprehensive financial data for the six months ended June 30, 2025. The presence of actual financial data and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, the appropriate classification is 'IR' for Interim / Quarterly Report with high confidence. H1 2025
2025-08-29 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025' and contains detailed financial data including consolidated statements of financial position, profit or loss, cash flow statements, notes to the unaudited interim financial report, and management discussion and analysis. It covers a six-month period ending June 30, 2025, which is a typical interim reporting period. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes comprehensive financial results, business review, and corporate governance information, consistent with an Interim / Quarterly Report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-29 English
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025' and contains detailed unaudited consolidated financial statements, including the Statement of Profit or Loss and Statement of Financial Position. It provides a comprehensive management discussion and analysis (MDA) of the company's performance for the interim period. It is not a mere announcement (RPA) as it contains the full financial data and analysis for the period. H1 2025
2025-08-28 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.